Tradestie Institutional Equity Comparison Engine

MPLT vs RACC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RACC Overall Edge

RACC Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to RACC (RACC) driven by superior Momentum & Technical, Options & Structure while MPLT counters with relative strength in Growth & Margin. Fundamentally, MPLT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus RACC at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MPLT sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro) against RACC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MPLT N/M vs RACC N/M Fwd P/E
Growth & Margin Winner MPLT
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner RACC
1Y -59.3% vs -2.7% ยท 52W Pos 0% vs 2%
Options & Structure Winner RACC
BREAKDOWN (9th %ile IV) vs UNCLASSIFIED (N/A IV)
MPLT US Equity
MapLight Therapeutics, Inc.
Pharmaceutical Preparations
$5.94
-7.48% 1D
Market Cap $356.8M
1M Return -28.0%
1Y Return -59.32%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 33.0 Fund 64.0 Flow 67.0 Mom 64.0
RACC US Equity
RACC
Institutional Equity
$10.02
+0.1% 1D
Market Cap N/A
1M Return -1.09%
1Y Return -2.72%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 39.0 Fund 38.0 Flow 50.0 Mom 38.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MPLT -59.32% RACC -2.72% Spread: +75.92 pp (RACC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MPLT TTM Op. Margin: 0.0% RACC TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MPLT vs RACC. Trailing 12-month operating profitability (MPLT 0.0% vs RACC N/A) and valuation multiples (MPLT N/M vs RACC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MPLT (6) vs RACC (2)
Institutional Metric MPLT RACC Criterion Row Winner
Market Capitalization Scale $356.8M N/A Larger Scale MPLT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% N/A Higher Growth MPLT
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin MPLT
Net Profit Margin Profitability 0.0% N/A Higher Margin MPLT
Return on Equity (ROE) Capital Efficiency -74.2% N/A Higher ROE MPLT
52-Week Range Position Momentum 0% ($6โ€“$40) 2% ($10โ€“$34) Stronger Trend RACC
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 79% Vol 0.16ฮฒ ยท 6% Vol Lower Realized Risk RACC
Unified Institutional Score Composite Signal 48.3 / 100 (HOLD) 42.1 / 100 (HOLD) Higher Composite MPLT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MPLT vs RACC Buy Guide
MPLT BREAKDOWN
148d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live MPLT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RACC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RACC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MPLT nor RACC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.